Paid Clinical Trials in Port Jefferson Station, NY
As of July 2026, 13 paid clinical trials are recruiting in Port Jefferson Station, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Port Jefferson Station offers studies at sites including North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists for conditions such as Breast Cancer, Acute Treatment of Migraine, Advanced Solid Tumor, Breast Cancer Metastatic. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Port Jefferson Station
Filter results
11 clinical trials
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Top Research Study Locations in Port Jefferson Station
Researchers run research studies in Port Jefferson Station, NY at 13 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
Active & Upcoming Studies in Port Jefferson Station (2026)
Recruiting trials in Port Jefferson Station grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (5 active studies)
- Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. · Phase 3 · BriaCell Therapeutics Corporation
- Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion · Phase 1 · Bristol-Myers Squibb
Neurology & pain (5 active studies)
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine · Phase 3 · Merz Therapeutics GmbH
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine · Phase 3 · Merz Therapeutics GmbH
Common conditions studied in Port Jefferson Station
- Breast Cancer (2 active studies)
- Acute Treatment of Migraine (1 active study)
- Advanced Solid Tumor (1 active study)
- Breast Cancer Metastatic (1 active study)
- Breast Neoplasm (1 active study)
- Carcinoma, Non-Small Cell Lung (1 active study)
Leading research sponsors in Port Jefferson Station
- Merz Therapeutics GmbH
- Pfizer
- AbbVie
- Boston Scientific Corporation
- BriaCell Therapeutics Corporation
Frequently asked questions
How many paid clinical trials are currently recruiting in Port Jefferson Station?
There are approximately 13 recruiting clinical trials in Port Jefferson Station, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Port Jefferson Station pay participants?
Most recruiting trials in Port Jefferson Station compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Port Jefferson Station?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Port Jefferson Station?
The most common conditions under active study in Port Jefferson Station include Breast Cancer (2), Acute Treatment of Migraine (1), Advanced Solid Tumor (1), Breast Cancer Metastatic (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Port Jefferson Station?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Port Jefferson Station on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Port Jefferson Station?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Port Jefferson Station?
Recruiting research sites in Port Jefferson Station include North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, True North Neurology, Merz Investigational, New york cancer and blood specialists - Oncology, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Port Jefferson Station right now?
The largest active categories in Port Jefferson Station are Cancer & tumors (5), Neurology & pain (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.